Scholarlink

<p>Viral vectors and protein nanoparticles represent important platforms in vaccine delivery, yet their potential synergy to overcome fundamental biological barriers remains largely unexplored. To address the challenge of pre-existing immunity against viral vectors, we rationally engineered a cationic human ferritin nanoparticle, termed (+)hF, designed to electrostatically assembles with adenovirus serotype 5 (Ad5) into a supramolecular complex. This construct was generated via structure-guided point mutations that introduced positive surface charges while retaining the innate self-assembly capability of the ferritin nanocage. The resulting (+)hF formed nanocomplexes with Ad5, which enhanced transgene expressions both in vitro and in vivo and effectively reduced sensitively to anti-Ad5 neutralization. In murine models with pre-existing immunity, intranasal immunization with (+)hF-complexed Ad5-based vaccines (encoding antigens for SARS-CoV-2 or Hendra virus) elicited significantly higher antigen-specific IgG and neutralizing antibody titers. A key advantage of (+)hF is its endogenous origin, which ensures high biocompatibility by preventing the induction of anti-carrier antibodies and any associated immune burden. This study presents a new paradigm that engineers programmable biointerfaces to synergize viral vectors with protein nanocages, offering a general strategy to circumvent critical biological barriers for enhanced vaccine and gene delivery.</p> Graphical abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Rationally engineered cationic ferritin nanoparticles overcome pre-existing immunity to adenoviral vectors

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月26日

查看全文
  • Yilong Yang,
  • Di Wang,
  • Yaohui Li,
  • Xiaofan Zhao,
  • Mengran Yi,
  • Xiaoyan Huang,
  • Xiaodong Zai,
  • Zhe Zhang,
  • Shipo Wu,
  • Jun Zhang,
  • Lihua Hou,
  • Junjie Xu,
  • Wei Chen

摘要

Viral vectors and protein nanoparticles represent important platforms in vaccine delivery, yet their potential synergy to overcome fundamental biological barriers remains largely unexplored. To address the challenge of pre-existing immunity against viral vectors, we rationally engineered a cationic human ferritin nanoparticle, termed (+)hF, designed to electrostatically assembles with adenovirus serotype 5 (Ad5) into a supramolecular complex. This construct was generated via structure-guided point mutations that introduced positive surface charges while retaining the innate self-assembly capability of the ferritin nanocage. The resulting (+)hF formed nanocomplexes with Ad5, which enhanced transgene expressions both in vitro and in vivo and effectively reduced sensitively to anti-Ad5 neutralization. In murine models with pre-existing immunity, intranasal immunization with (+)hF-complexed Ad5-based vaccines (encoding antigens for SARS-CoV-2 or Hendra virus) elicited significantly higher antigen-specific IgG and neutralizing antibody titers. A key advantage of (+)hF is its endogenous origin, which ensures high biocompatibility by preventing the induction of anti-carrier antibodies and any associated immune burden. This study presents a new paradigm that engineers programmable biointerfaces to synergize viral vectors with protein nanocages, offering a general strategy to circumvent critical biological barriers for enhanced vaccine and gene delivery.

Graphical abstract